Low-Dose Colchicine for the Management of Coronary Artery Disease

被引：0
|
作者：
Tardif, Jean-Claude [1 ]
Marquis-Gravel, Guillaume [1 ]
机构：
[1] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 78卷 / 09期
关键词：
anti-inflammatory agents; atherosclerosis; cardiovascular inflammation; ischemic risk; myocardial infarction; secondary prevention; SECONDARY PREVENTION; METAANALYSIS;
D O I：
10.1016/j.jacc.2021.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：867 / 869
页数：3
相关论文
共 50 条
  • [31] Management of Morgellons Disease With Low-Dose Trifluoperazine
    Yan, Bernice Y.
    Jorizzo, Joseph L.
    JAMA DERMATOLOGY, 2018, 154 (02) : 216 - 218
  • [32] High- but not low-dose folic acid improves endothelial function in coronary artery disease
    Moat, S. J.
    Madhavan, A.
    Taylor, S. Y.
    Payne, N.
    Allen, R. H.
    Stabler, S. P.
    Goodfellow, J.
    McDowell, I. F. W.
    Lewis, M. J.
    Lang, D.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (12) : 850 - 859
  • [33] Effects of low-dose atorvastatin therapy on the insulin and lipid levels in patients with coronary artery disease
    Yegorova, Y. V.
    Kuryata, D. V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 580 - 580
  • [34] Comments in response to "Low-dose aspirin increases aspirin resistance in patients with coronary artery disease"
    Fisher, M
    Knappertz, V
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (03): : 287 - 287
  • [35] Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease
    Ito, MK
    Shabetai, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (06): : 799 - +
  • [36] Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
    Zhao, Yuhong
    Peng, Ran
    Zhao, Wang
    Liu, Qiong
    Guo, Yuan
    Zhao, Shuiping
    Xu, Danyan
    MEDICINE, 2017, 96 (07)
  • [37] Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
    Dagenais, Gilles R.
    Dyal, Leanne
    Bosch, Jacqueline J.
    Leong, Darryl P.
    Aboyans, Victor
    Berkowitz, Scott D.
    Bhatt, Deepak L.
    Connolly, Stuart J.
    Fox, Keith A. A.
    Muehlhofer, Eva
    Probstfield, Jeffrey L.
    Widimsky, Petr
    Winkelmann, Bernhard R.
    Yusuf, Salim
    Eikelboom, John W.
    HEART, 2021, 107 (14) : 1130 - 1137
  • [38] Functional Assessment of Coronary Artery Disease Using Low-dose Dynamic Computed Tomography Perfusion
    Hubbard, Logan
    Ziemer, Benjamin
    Lipinski, Jerry
    Sadeghi, Bahman
    Javan, Hanna
    Groves, E. M.
    Molloi, Sabee
    CIRCULATION, 2015, 132
  • [39] Effect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery Disease
    Choi, Chang Kyu
    Kim, Nayoung
    Choi, Jin Woo
    Park, Young Soo
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Lee, Dong Ho
    Cho, Young-Seok
    Youn, Tae-Jin
    Chung, Woo-Young
    Chae, In-Ho
    Choi, Dong-Ju
    GUT AND LIVER, 2008, 2 (02) : 99 - 104
  • [40] Evidence for variable platelet response to low-dose aspirin in patients with coronary artery disease.
    von Pape, KW
    Strupp, G
    Bonzel, T
    Bohner, J
    BLOOD, 2000, 96 (11) : 652A - 652A
12345